Petlife Pharmaceuticals, Inc. (PTLF)
PTLF Stock Price Chart
Explore Petlife Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze PTLF price movements and trends.
PTLF Company Profile
Discover essential business fundamentals and corporate details for Petlife Pharmaceuticals, Inc. (PTLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
14 May 2008
Employees
1.00
CEO
Sebastian Serrell-Watts
Description
Petlife Pharmaceuticals, Inc. engages in the research, development, sale, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis in the United States. The company's principal product is Vitalzul that inhibits blood vessels formation in solid tumors. It is also developing Vitalzul as a prescription strength oral pharmaceutical, as well as a concentrated intravenous and injectable version for direct administration to a tumor. In addition, the company develops edible dog and cat treats. Petlife Pharmaceuticals, Inc. is based in Los Angeles, California.
PTLF Financial Timeline
Browse a chronological timeline of Petlife Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
PTLF Stock Performance
Access detailed PTLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.